catechol and beta-resorcylic acid

catechol has been researched along with beta-resorcylic acid in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (50.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Günzler, V; Hanauske-Abel, HM; Kivirikko, KI; Majamaa, K; Myllylä, R	1
Cohen, SM; Fullagar, JL; Jacobsen, JA; Miller, MT	1

Other Studies

2 other study(ies) available for catechol and beta-resorcylic acid

Article	Year
Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase. The Journal of biological chemistry, 1986, Jun-15, Volume: 261, Issue:17 Topics: Animals; Ascorbic Acid; Binding Sites; Chick Embryo; Ketoglutaric Acids; Kinetics; Phenols; Procollagen-Proline Dioxygenase; Protein Binding; Structure-Activity Relationship; Substrate Specificity	1986
Identifying chelators for metalloprotein inhibitors using a fragment-based approach. Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2 Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc	2011

Article

Year

Partial identity of the 2-oxoglutarate and ascorbate binding sites of prolyl 4-hydroxylase.

The Journal of biological chemistry, 1986, Jun-15, Volume: 261, Issue:17

Topics: Animals; Ascorbic Acid; Binding Sites; Chick Embryo; Ketoglutaric Acids; Kinetics; Phenols; Procollagen-Proline Dioxygenase; Protein Binding; Structure-Activity Relationship; Substrate Specificity

1986

Identifying chelators for metalloprotein inhibitors using a fragment-based approach.

Journal of medicinal chemistry, 2011, Jan-27, Volume: 54, Issue:2

Topics: Antigens, Bacterial; Bacterial Toxins; Chelating Agents; Copper; Drug Design; Humans; Hydroxyquinolines; Iron; Ligands; Lipoxygenase Inhibitors; Matrix Metalloproteinase Inhibitors; Matrix Metalloproteinases; Monophenol Monooxygenase; Nitric Oxide Synthase Type II; Recombinant Proteins; Small Molecule Libraries; Structure-Activity Relationship; Sulfonamides; Zinc

2011